Biotechnology (10) | Funding Agreements (10)

Browse by Company

BioCardia, Inc. (1)
Biohaven Pharmaceutical Holding Co Ltd. (1)
Cytokinetics, Incorporated (1)
DiaMedica Therapeutics Inc. (1)
Kodiak Sciences Inc. (1)
NOVAVAX INC (2)
VBI Vaccines Inc (1)
VICAL INC (1)
Xenetic Biosciences, Inc. (1)

Recent Contracts

Funding Agreement, by and between Variation Biotechnologies Inc., a Canadian federal corporation and a wholly-owned subsidiary of VBI Vaccines Inc., and the Coalition for Epidemic... (VBI Vaccines Inc, Filed With SEC on May 10, 2021)
Amendment Number 1 to the iPDP and Budget of the Outbreak Response Funding Agreement (Step 2), entered into on November 2, 2020, between Novavax, Inc. and the Coalition for... (NOVAVAX INC, Filed With SEC on March 1, 2021)
Funding Agreement by and (Biohaven Pharmaceutical Holding Co Ltd., Filed With SEC on November 9, 2020)
Funding Agreement, dated July 14, 2020, by and between the Company and Dolya Holdco 19 Designated Activity Company (Cytokinetics, Incorporated, Filed With SEC on November 6, 2020)
Research Funding and Option Agreement, dated May 15, 2020, between the Company and the Scripps Research Institute (Xenetic Biosciences, Inc., Filed With SEC on August 12, 2020)
Restated Funding Agreement, entered into on May 11, 2020, by and between the Company and the Coalition for Epidemic Preparedness Innovations (NOVAVAX INC, Filed With SEC on August 10, 2020)
Litigation Funding Agreement dated April 9, 2020, between BSLF, L.L.C. and BioCardia, Inc (BioCardia, Inc., Filed With SEC on April 14, 2020)
Litigation Funding Agreement, dated as of December 27, 2019, between LEGALIST FUND II, L.P. and DiaMedica Therapeutics Inc (DiaMedica Therapeutics Inc., Filed With SEC on January 3, 2020)
Funding Agreement, dated as of December 1, 2019, between Kodiak Sciences Inc., Kodiak Sciences GmbH and Baker Bros. Advisors, LP (Kodiak Sciences Inc., Filed With SEC on December 2, 2019)
Funding Agreement, as amended, dated June 2, 2019, by and between Brickell Biotech, Inc. and NovaQuest Co-Investment Fund X, L.P (VICAL INC, Filed With SEC on September 3, 2019)